The European Commission has made a 336 million euro ($396 million) downpayment to British drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-19 vaccine, a spokesman said on Thursday. The deal covers development, liability and other costs faced by the vaccine maker. The EU has also secured an option to … Continue reading EU secures AstraZeneca’s potential COVID-19 vaccine